Kolaviron
In vitro / AnimalMechanism of Action
Research Notes
Extensive preclinical evidence in rodent models shows kolaviron protects against carbon tetrachloride-, alcohol-, and aflatoxin-induced hepatotoxicity; reduces fasting blood glucose comparably to glibenclamide in diabetic models; and demonstrates broad-spectrum antimicrobial and anti-inflammatory activity. Phase I human safety data from Nigerian academic centres indicate tolerability; Phase II efficacy trials in hepatic and diabetic endpoints are ongoing as of 2024.
Multiple rodent studies demonstrate hepatoprotective activity against carbon tetrachloride and acetaminophen-induced liver injury. Anti-inflammatory and antidiabetic effects have been documented in vitro and in vivo, though human clinical trials remain limited.
Found In 2 Herbs
3D Molecular Structure
Kolaviron
Representative pattern: C₁₅H₁₀O₃
Live Research
This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare practitioner before using any herbal product.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This content is for educational purposes only and is not a substitute for professional medical advice.
